Executive summary

Flixonase is a challenger brand in the category of remedies for the symptoms of allergic rhinitis. It had a small market share due to its premium positioning as a prescription drug. 2018 became the year in which Flixonase was to be fully launched in the over-the-counter (OTC) category, so it posed both a huge challenge and an unprecedented opportunity to enter this competitive market – the brand needed to maximise its visibility.

Based on the insight that allergies and pollen always come at the wrong time, we created a predictive AI-based map that allows the audience to know in advance when pollen becomes present in their city. Moreover, this was achieved in the country with the biggest landmass in the world: Russia.

We believe that effective marketing is based on facts, not opinions

Since 1985, we’ve brought confidence to marketing decisions through the most trusted research, case studies, best practice, data and inspiration. Today, we help 75,000+ marketers across 100+ countries.

Learn more about why marketers rely on us to help make their marketing effective